← Back to the fund page Use your browser's print dialog and choose “Save as PDF”. A4.
MF Analyser

HDFC MNC Fund

Direct Plan · IDCW Option · Sectoral / Thematic · Scheme code 151460

NAV₹14.4670as on 25 Sep 2026
Fund houseHDFC Mutual Fund
CategorySectoral / Thematic
Plan & optionDirect · IDCW Option
History3.5 years

Returns (%)

 1M3M6M1Y3Y5Y7Y10YLaunch
This scheme -4.662.1310.22 -0.016.83— ——10.61
Nifty 500
benchmark		 0.874.312.15 5.2012.4911.41 ——15.49
Sectoral / Thematic
category median		 ——— 3.5214.6711.99 —14.72—

Over a year annualised (CAGR), under a year absolute. Computed from AMFI's published NAV history for this scheme.

Risk

 VolatilitySharpeSortinoBetaAlphaMax fallR²
This scheme 12.2% 0.03 0.04 0.98 -3.36% -24.5% 85.46
Nifty 500
benchmark		 17.2%0.35 0.47—— -37.3%—

Risk-free rate 6.5%. Beta, alpha and R² are regressed on the 41 months this scheme and its benchmark share.

Growth of ₹100 since launch

9511713916020242026MF Analyser

Drawdown from peak (%)

0%-9%-18%-27%20242026

Every one-year period it has lived through

WindowsWorstMedianBestPeriods that lost money
125 -10.5% 4.7% 36.1% 35%

Every one-year holding period in this scheme's history, not just the last one — the spread a real investor would have met depending only on when they started.

How it behaves against its benchmark

Up captureDown captureCorrelation Tracking errorInformation ratioTreynor
87% 95% 0.92 5.9% -0.60 6.03

Up capture is how much of the benchmark's gain this scheme kept in the months the benchmark rose; down capture, how much of its fall it took. Below 100 on the down side and above it on the up side is the combination every fund is trying for and few reach. Measured over the 41 months this scheme and Nifty 500 share.

MF Analyser

HDFC MNC Fund

Direct Plan · IDCW Option

Allocation

By asset

Equity99.06%
Cash & Equivalents0.94%

By market cap

Large Cap52.38%
Mid Cap28.52%
Small Cap14.97%
Unclassified3.19%

Concentration

Number of stocks42
Top 5 stocks31.29%
Top 10 stocks49.79%
Top 20 stocks74.57%
Lines in the filing44
Largest holding9.03%
Largest sectorPharmaceuticals & Biotechnology 23.52%
Effective stocks26.9
Sectors held17
Cash0.94%

Effective stocks is what the concentration works out to: a fund holding 42 names but most of its money in a few behaves like a fund of 27. Cash includes repo and TREPS, which every fund parks money in overnight.

Sector split

Pharmaceuticals & Biotechnology — 23.5%Automobiles — 12.0%Food Products — 11.6%Industrial Products — 8.2%Auto Components — 8.0%Electrical Equipment — 7.4%Diversified FMCG — 6.1%Beverages — 4.6%Agricultural, Commercial & Construction Vehicles — 3.5%Other — 15.1%Pharmaceuticals & Biotech…23.5%Automobiles12.0%Food Products11.6%Industrial Products8.2%Auto Components8.0%Electrical Equipment7.4%Diversified FMCG6.1%Beverages4.6%Agricultural, Commercial …3.5%Other15.1%
Pharmaceuticals & Biotechnology23.52%
Automobiles11.98%
Food Products11.58%
Industrial Products8.23%
Auto Components7.97%
Electrical Equipment7.44%
Diversified FMCG6.05%
Beverages4.56%
Agricultural, Commercial & Construction Vehicles3.53%
Consumer Durables2.89%
Textiles & Apparels2.50%
Diversified Metals1.84%
Non - Ferrous Metals1.73%
IT - Software1.71%
Healthcare Equipment & Supplies1.51%
Cement & Cement Products1.22%
Cash & Equivalents0.94%
Industrial Manufacturing0.80%
MF Analyser

HDFC MNC Fund

Direct Plan · IDCW Option · holdings

Top 30 holdings

#CompanySectorShares held Value
₹ cr		% of fund
1 Maruti Suzuki India Limited Automobiles 37,763 51 9.03%
2 Britannia Industries Ltd. Food Products 69,909 37 6.48%
3 Hindustan Unilever Ltd. Diversified FMCG 174,224 34 6.05%
4 Nestle India Ltd. Food Products 193,072 29 5.10%
5 Cummins India Ltd. Industrial Products 51,360 26 4.63%
6 United Spirits Limited Beverages 173,156 26 4.56%
7 Bosch Limited Auto Components 4,461 22 3.94%
8 Torrent Pharmaceuticals Ltd. Pharmaceuticals & Biotechnology 43,000 22 3.85%
9 Timken India Ltd. Industrial Products 55,292 17 3.08%
10 Neuland Laboratories Limited Pharmaceuticals & Biotechnology 7,550 17 3.07%
11 Hyundai Motor India Limited Automobiles 75,671 17 2.95%
12 LG Electronics India Limited Consumer Durables 96,500 16 2.89%
13 Ajanta Pharma Limited Pharmaceuticals & Biotechnology 43,522 16 2.77%
14 Ashok Leyland Ltd Agricultural, Commercial & Construction Vehicles 830,000 15 2.57%
15 Sun Pharmaceutical Industries Ltd. Pharmaceuticals & Biotechnology 72,500 14 2.54%
16 PEARL GLOBAL INDUSTRIES LIMITED Textiles & Apparels 57,557 14 2.50%
17 Gland Pharma Ltd. Pharmaceuticals & Biotechnology 43,500 13 2.22%
18 Divis Laboratories Ltd. Pharmaceuticals & Biotechnology 13,050 12 2.18%
19 Anthem Biosciences Limited Pharmaceuticals & Biotechnology 132,034 12 2.08%
20 GE Vernova T&D India Limited Electrical Equipment 26,450 12 2.08%
21 ABB India Ltd. Electrical Equipment 15,135 12 2.04%
22 Vedanta Ltd. Diversified Metals 375,000 10 1.84%
23 Vedanta Aluminium Metal Limited Non - Ferrous Metals 225,000 10 1.73%
24 TENNECO CLEAN AIR INDIA LIMITED Auto Components 170,464 9 1.59%
25 Molbio Diagnostics Limited Healthcare Equipment & Supplies 78,858 9 1.51%
26 Oracle Financial Ser Software Ltd. IT - Software 6,600 8 1.46%
27 Sona Blw Precision Forgings Auto Components 99,500 8 1.43%
28 Hitachi Energy India Ltd. Electrical Equipment 2,375 8 1.42%
29 TREPS - Tri-party Repo Unclassified — 8 1.41%
30 Ipca Laboratories Ltd. Pharmaceuticals & Biotechnology 36,900 7 1.29%
MF Analyser

HDFC MNC Fund

Direct Plan · IDCW Option · where the money sits

What the manager did last month

Between the filings of 31 Jul 2026 and 31 Aug 2026. A position grows because the manager bought or because the price rose; only the share count separates them.

BoughtSoldNew positionsSold out ofPrice move of holdings
₹9 cr ₹14 cr 6 6 +3.08%
StockShares tradedShares PriceValue
₹ cr
New position
Torrent Pharmaceuticals Ltd. 43,000 entered — 21.8
Molbio Diagnostics Limited 78,858 entered — 8.6
Rubicon Research Limited 29,856 entered — 5.4
SYMBIOTEC PHARMALAB LIMITED 50,610 entered — 5.0
Lupin Ltd. 16,774 entered — 3.7
HEG Ltd 40,305 entered — 2.9
Added to
LG Electronics India Limited 34,900 +56.7% +13.9% 5.9
TENNECO CLEAN AIR INDIA LIMITED 48,464 +39.7% -1.6% 2.6
Gland Pharma Ltd. 2,000 +4.8% +15.3% 0.6
Novartis India Ltd. 1,391 +7.3% +1.1% 0.2
Trimmed
Wockhardt Ltd. 17,614 -55.5% -3.9% 3.3
Anthem Biosciences Limited 33,000 -20.0% +10.4% 3.0
Hyundai Motor India Limited 9,750 -11.4% +1.1% 2.2
GE Vernova T&D India Limited 3,750 -12.4% +2.8% 1.7
Ajanta Pharma Limited 4,081 -8.6% +3.9% 1.5
Ipca Laboratories Ltd. 6,000 -14.0% +13.0% 1.2
ABB India Ltd. 1,500 -9.0% +4.9% 1.2
Sold out of
Tata Motors Limited 238,000 exited — 10.4
Hexaware Technologies Ltd. 115,000 exited — 6.5
Biocon Ltd. 131,436 exited — 5.6
Glenmark Pharmaceuticals Ltd. 18,800 exited — 4.2
HCL Technologies Ltd. 25,000 exited — 3.4
Tata Consultancy Services Ltd. 12,500 exited — 3.0
Not equityPrevious filingThis filingChange
Cash, repo and TREPS ₹0 cr ₹0 cr +₹0 cr

The list above is stocks and fund units. Treasury bills, repo and money-market lines roll over every month by design — they are not decisions, so they are totalled here rather than listed as activity.

Not investment advice. InvestVerdict is not a SEBI-registered Investment Adviser or Research Analyst. Every figure is computed from AMFI's published NAV history and the portfolio the AMC filed with AMFI; none of it is a recommendation to buy, hold or sell. Past returns do not predict future ones. Generated 27 Sep 2026.